Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
1.
Transpl Infect Dis ; 14(5): E71-81, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22862881

ABSTRACT

Bartonella henselae, the etiologic agent of cat-scratch disease, causes a well-defined, self-limited syndrome of fever and regional lymphadenopathy in immunocompetent hosts. In immunocompromised hosts, however, B. henselae can cause severe disseminated disease and pathologic vasoproliferation known as bacillary angiomatosis (BA) or bacillary peliosis. BA was first recognized in patients infected with human immunodeficiency virus. It has become more frequently recognized in solid organ transplant (SOT) recipients, but reports of pediatric cases remain rare. Our review of the literature revealed only one previously reported case of BA in a pediatric SOT recipient. We herein present 2 pediatric cases, one of which is the first reported case of BA in a pediatric cardiac transplant recipient, to our knowledge. In addition, we review and summarize the literature pertaining to all cases of B. henselae-mediated disease in SOT recipients.


Subject(s)
Angiomatosis, Bacillary/diagnosis , Bartonella henselae/isolation & purification , Cat-Scratch Disease/diagnosis , Heart Transplantation/adverse effects , Kidney Transplantation/adverse effects , Angiomatosis, Bacillary/drug therapy , Angiomatosis, Bacillary/microbiology , Animals , Anti-Bacterial Agents/therapeutic use , Cat-Scratch Disease/drug therapy , Cat-Scratch Disease/microbiology , Cats , Child , Female , Humans , Male
2.
Fetal Pediatr Pathol ; 31(2): 54-62, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22409406

ABSTRACT

Splenic cysts are rare lesions that can occur in parasitic and non-parasitic forms. Because they are uncommon, the classification, pathogenesis, and management techniques are still debated. The continual review of splenic cyst cases in the pediatric population is essential for establishing a clear diagnosis and course of treatment. This report presents 21 cases of pediatric splenic cysts observed at Children's Healthcare of Atlanta over an 18 year period (1993-2011). The cases include both parasitic and and nonparasitic cysts. The current splenic cyst classification and treatment methods are analyzed through a review of the current theories and based on our experiences.


Subject(s)
Cysts/pathology , Splenic Diseases/pathology , Adolescent , Child , Child, Preschool , Cysts/etiology , Cysts/surgery , Female , Humans , Male , Splenectomy , Splenic Diseases/etiology , Splenic Diseases/surgery
3.
Fetal Pediatr Pathol ; 31(3): 145-53, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22413928

ABSTRACT

Proteus syndrome (PS) is a rare, progressive disorder that manifests as asymmetric, disproportionate overgrowth affecting tissues derived from any germline layer. Cases of PS from 2005-2010 were retrieved from the pathology files at our institution. Two confirmed cases and one possible case of PS were identified. All patients came from different ethnic backgrounds. Patient 1 displayed classic skin and overgrowth lesions. Patient 2 displayed various features, particularly vascular malformations. Patient 3 demonstrated a cerebriform connective tissue nevus alone. These patients demonstrate the spectrum of presentations of PS. Much is left to learn about this disfiguring disease.


Subject(s)
Proteus Syndrome/pathology , Child, Preschool , Diseases in Twins/pathology , Female , Humans , Infant , Infant, Newborn , Male , Twins, Dizygotic
4.
J Pediatr Surg ; 36(12): 1832-3, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11733917

ABSTRACT

Esophageal leiomyomas are rare in the pediatric population. They frequently occur in association with other anomalies, such as Alport's syndrome, osteoarthropathy, and leiomyomas elsewhere in the body. The authors describe the case of a focal esophageal leiomyoma in a 12-month-old girl with a history of long-gap esophageal atresia. The patient initially underwent bouginage of the proximal pouch while awaiting definitive repair. After esophageal repair, the patient required multiple dilatations for anastomotic strictures. A segmental resection of the esophagus was performed because of recurrent strictures. A leiomyoma, arising from the site of the previous esophageal atresia repair, was noted on histologic evaluation. Esophageal leiomyomas have not been reported previously in a child with esophageal atresia. J Pediatr Surg 36:1832-1833.


Subject(s)
Esophageal Atresia/surgery , Esophageal Neoplasms/etiology , Leiomyoma/etiology , Postoperative Complications/etiology , Anastomosis, Surgical , Dilatation/adverse effects , Esophageal Atresia/pathology , Esophageal Neoplasms/pathology , Esophageal Neoplasms/surgery , Esophagectomy , Esophagus/pathology , Esophagus/surgery , Female , Humans , Infant , Infant, Newborn , Leiomyoma/pathology , Leiomyoma/surgery , Postoperative Complications/pathology , Postoperative Complications/surgery , Treatment Outcome
5.
Am J Obstet Gynecol ; 185(5): 1209-17, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11717659

ABSTRACT

OBJECTIVE: The purpose of this study was to assess presumptive sexually transmitted disease treatment on pregnancy outcome and HIV transmission. STUDY DESIGN: In a randomized trial in Rakai District, Uganda, 2070 pregnant women received presumptive sexually transmitted disease treatment 1 time during pregnancy at varying gestations, and 1963 control mothers received iron/folate and referral for syphilis. Maternal-infant sexually transmitted disease/HIV and infant outcomes were assessed. Intent-to-treat analyses estimated adjusted rate ratios and 95% confidence intervals. RESULTS: Sexually transmitted diseases were reduced: Trichomonas vaginalis (rate ratio, 0.28; 95% CI, 0.18%-0.49%), bacterial vaginosis (rate ratio, 0.78; 95% CI, 0.69-0.87), Neisseria gonorrhoeae /Chlamydia trachomatis (rate ratio, 0.43; 95% CI, 0.27-0.68), and infant ophthalmia (rate ratio, 0.37; 95% CI, 0.20-0.70). There were reduced rates of neonatal death (rate ratio, 0.83; 95% CI, 0.71-0.97), low birth weight (rate ratio, 0.68; 95% CI, 0.53-0.86), and preterm delivery (rate ratio, 0.77; 95% CI, 0.56-1.05); but there were no effects on maternal HIV acquisition or perinatal HIV transmission. CONCLUSION: Reductions of maternal sexually transmitted disease improved pregnancy outcome but not maternal HIV acquisition or perinatal HIV transmission.


Subject(s)
Azithromycin/therapeutic use , Cefixime/therapeutic use , Metronidazole/therapeutic use , Pregnancy Complications, Infectious/therapy , Sexually Transmitted Diseases/therapy , Birth Weight , Drug Therapy, Combination , Endophthalmitis/prevention & control , Female , Folic Acid/therapeutic use , HIV Infections/therapy , Humans , Infant , Infant Mortality , Infant, Newborn , Infant, Newborn, Diseases/prevention & control , Infant, Premature , Iron/therapeutic use , Obstetric Labor, Premature/prevention & control , Pregnancy , Sexually Transmitted Diseases/prevention & control , Uganda
6.
N Engl J Med ; 342(17): 1250-3, 2000 Apr 27.
Article in English | MEDLINE | ID: mdl-10781621

ABSTRACT

BACKGROUND AND METHODS: Enteritis necroticans (pigbel), an often fatal illness characterized by hemorrhagic, inflammatory, or ischemic necrosis of the jejunum, occurs in developing countries but is rare in developed countries, where its occurrence is confined to adults with chronic illnesses. The causative organism of enteritis necroticans is Clostridium perfringens type C, an anaerobic gram-positive bacillus. In December 1998, enteritis necroticans developed in a 12-year-old boy with poorly controlled diabetes mellitus after he consumed pig intestines (chitterlings). He presented with hematemesis, abdominal distention, and severe diabetic ketoacidosis with hypotension. At laparotomy, extensive jejunal necrosis required bowel resection, jejunostomy, and ileostomy. Samples were obtained for histopathological examination. Polymerase-chain-reaction (PCR) assay was performed on paraffin-embedded bowel tissue with primers specific for the cpa and cpb genes, which code for the alpha and beta toxins produced by C. perfringens. RESULTS: Histologic examination of resected bowel tissue showed extensive mucosal necrosis, the formation of pseudomembrane, pneumatosis, and areas of epithelial regeneration that alternated with necrotic segments--findings consistent with a diagnosis of enteritis necroticans. Gram's staining showed large gram-positive bacilli whose features were consistent with those of clostridium species. Through PCR amplification, we detected products of the cpa and cpb genes, which indicated the presence of C. perfringens type C. Assay of ileal tissue obtained during surgery to restore the continuity of the patient's bowel was negative for C. perfringens. CONCLUSIONS: The preparation or consumption of chitterlings by diabetic patients and other chronically ill persons can result in potentially life-threatening infectious complications.


Subject(s)
Clostridium perfringens , Diabetes Mellitus, Type 1/complications , Enterocolitis, Necrotizing/microbiology , Foodborne Diseases , Meat Products/microbiology , Animals , Child , Clostridium Infections/transmission , Clostridium Infections/veterinary , Clostridium perfringens/genetics , Clostridium perfringens/isolation & purification , Diabetic Ketoacidosis/etiology , Enterocolitis, Necrotizing/complications , Food Microbiology , Hematemesis/etiology , Humans , Ileum/microbiology , Ileum/pathology , Ileum/surgery , Jejunum/pathology , Jejunum/surgery , Male , Necrosis , Swine
7.
J Acquir Immune Defic Syndr ; 22(4): 379-85, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-10634200

ABSTRACT

UNLABELLED: Prospective follow-up of 172 HIV-infected pregnant women and their infants was conducted at Mulago Hospital, Kampala, Uganda during 1990 to 1992. Information was collected on maternal immune status (CD4 counts or clinical AIDS), and concurrent infections with sexually transmitted diseases. Infants were observed on a follow-up basis to determine HIV infection, using polymerase chain reaction (PCR) under 15 months of age and enzyme immunoassay/Western blot for those older than 15 months. Placental membrane inflammation (chorioamnionitis and funisitis), and placental villous inflammation (villitis, intervillitis, and deciduitis) were diagnosed by histopathology. Mother-to-child HIV transmission rates were assessed, and adjusted odds ratios (OR) and 95% confidence intervals (95% CI) of transmission were estimated using women with no placental pathology or evidence of immune suppression as a reference group. RESULTS: The overall mother-to-child HIV transmission rate was 23.3%. Women with no placental membrane inflammation or immune suppression had a transmission rate of 11.3%; compared with 25.5% in women with placental inflammation and no immunosuppression (adjusted OR, 2.87; 95% CI, 1.04-7.90), and 37.0% in immunosuppressed women (OR, 3.07; 95% CI, 1.42-6.67). We estimate that 34% of HIV transmission could be prevented by treatment of placental membrane inflammation in nonimmunocompromised women. Transmission rates were 40.9% with genital ulcer disease (OR, 3.57; 95% CI, 1.28-9.66). Placental villous inflammation and artificial rupture of membranes did not increase transmission rates and cesarean section was associated with a nonsignificant reduction of risk (OR, 0.70; 95% CI 0.24-2.06). CONCLUSION: Placental membrane inflammation increases the rate of mother-to-child HIV transmission.


Subject(s)
HIV Infections/transmission , HIV-1 , Infectious Disease Transmission, Vertical , Placenta Diseases/complications , Pregnancy Complications, Infectious , Blotting, Western , Chorioamnionitis/complications , Chorioamnionitis/pathology , Female , HIV Infections/complications , HIV Infections/virology , HIV-1/isolation & purification , Humans , Immunocompromised Host , Immunoenzyme Techniques , Infant , Infant, Newborn , Inflammation , Placenta Diseases/pathology , Polymerase Chain Reaction , Pregnancy , Pregnancy Complications, Infectious/virology , Uganda
8.
Arch Pathol Lab Med ; 122(6): 562-5, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9625428

ABSTRACT

Both an enlarged thymus (with normal results on histologic examination) and an increase in the percentage of peripheral CD4+CD45RA+ (naive) T lymphocytes developed in a child with chronic granulomatous disease receiving long-term interferon gamma therapy. The thymic regrowth may be secondary to interferon gamma therapy or to overstimulation of his compromised immune system by recurrent infections. To our knowledge, an association between enlargement of the thymus and either chronic granulomatous disease or interferon gamma has not been previously reported.


Subject(s)
Granulomatous Disease, Chronic/drug therapy , Interferon-gamma/adverse effects , Thymus Gland/pathology , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , Child , Granulomatous Disease, Chronic/diagnostic imaging , Humans , Hypertrophy/chemically induced , Hypertrophy/diagnostic imaging , Leukocyte Common Antigens/immunology , Male , Radiography, Thoracic , Thymus Gland/drug effects , Thymus Gland/immunology , Tomography, X-Ray Computed
9.
Pediatr Surg Int ; 12(4): 299-301, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9099651

ABSTRACT

We describe a case of an inflammatory pseudotumor of the spleen in a 5-year-old boy, found incidentally during a physical examination. The boy underwent a hemisplenectomy. The problems in differentiating this disease from lymphoma of the spleen before surgery and the advantages of hemisplenectomy are discussed. This rare disease has previously been described in the spleen in only 28 cases, the youngest being a 16-year-old patient.


Subject(s)
Granuloma, Plasma Cell/diagnosis , Splenic Diseases/diagnosis , Child, Preschool , Diagnosis, Differential , Granuloma, Plasma Cell/epidemiology , Granuloma, Plasma Cell/surgery , Humans , Magnetic Resonance Imaging , Male , Splenectomy , Splenic Diseases/epidemiology , Splenic Diseases/surgery
10.
AJNR Am J Neuroradiol ; 18(2): 239-45, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9111658

ABSTRACT

PURPOSE: To determine the MR and CT appearance of the normal pediatric larynx. METHODS: Fifteen CT scans and 15 MR examinations of children with normal larynges and airways were reviewed retrospectively. Characteristics that were noted included the level of the hyoid bone, calcification and signal intensity within separate laryngeal components, amount of paraglottic fat, anteroposterior airway diameters, and airway contours. Two cadaveric larynges were imaged by CT and MR and were then sectioned at corresponding levels and section thicknesses. RESULTS: The larynx is higher in children than in adults, with the hyoid bone found at the C2-3 level in the youngest children (newborn to 2 years). The subglottic airway was narrowest in the youngest children. The hyoid bone was the only laryngeal structure ossified in any of the children. A thin line of high density was seen in the expected location of the thyroid cartilage in some children. The featureless circumferential soft tissue seen around the airway represented the uncalcified laryngeal cartilaginous structures. This was confirmed on gross sectioning of cadaveric larynges. The supraglottic airway contour was triangular or oval, the glottis was shaped like a teardrop, and the subglottic contour was oval. Contours were confirmed on histologic examination of necropsy specimens. CONCLUSIONS: This preliminary study suggests that the pediatric larynx differs from the adult larynx with respect to size, position, consistency, and shape, and these differences are reflected on CT and MR studies.


Subject(s)
Larynx/anatomy & histology , Larynx/diagnostic imaging , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Adolescent , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Reference Values , Retrospective Studies
11.
J Pediatr Surg ; 32(10): 1476-9, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9349774

ABSTRACT

Fetus-in-fetu is an unusual condition in which a vertebrate fetus is enclosed within the abdomen of another fetus. These occurrences are usually benign. This report describes an instance of malignant recurrence after resection of a fetus-in-fetu.


Subject(s)
Fetus/abnormalities , Neoplasm Recurrence, Local/pathology , Peritoneal Neoplasms/pathology , Teratoma/pathology , Diagnosis, Differential , Humans , Infant, Newborn , Magnetic Resonance Imaging , Male , Neoplasm Recurrence, Local/blood , Neoplasm Recurrence, Local/surgery , Peritoneal Neoplasms/blood , Peritoneal Neoplasms/surgery , Teratoma/blood , Teratoma/surgery , alpha-Fetoproteins/analysis
13.
Placenta ; 17(1): 57-68, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8710814

ABSTRACT

An improved method for long-term perfusion of the isolated human term placental lobule has been developed to investigate the maternofetal transfer of infectious agents, in particular the human immunodeficiency virus (HIV). The purpose of this paper is to describe those modifications that allow for substantially prolonged perfusions in in a biohazard environment. The method described has been adapted from previous models. The perfusion apparatus has been modified for use within a biohazard hood, and, intravenous bags contain the medium for circulation of perfusates in closed circuits. A Mera Silox-S 0.3 membrane oxygenator delivers more oxygen to the tissue, and, Electromedic Cardioplegia heat exchangers warm the perfusate prior to oxygenation. Viability criteria (glucose consumption, lactate production, de novo production of human placental lactogen (hPL), volume loss, flow, temperature, pressure, oxygen transfer, carbon dioxide production, absence of IgM transfer and light and electron microscopy) demonstrate that the placental tissue remains in a functional state throughout the perfusion. Oxygen and glucose consumption are both stable over time; lactate levels remain constant; and hPL continues to be produced. These significant modifications of the perfusion system have permitted the investigators to increase the duration of perfusion to 48 h while preserving normal metabolic function of ultrastructurally intact tissue as demonstrated by ultra structural observations. This perfusion model device provides biohazard precautions and may be applied to other studies of placental physiology.


Subject(s)
Infections/transmission , Maternal-Fetal Exchange , Oxygen Consumption , Perfusion , Placenta/metabolism , Carbon Dioxide/blood , Chorionic Villi/blood supply , Chorionic Villi/ultrastructure , Female , Glucose/metabolism , Humans , Immunoglobulin M/metabolism , Kinetics , Microscopy, Electron , Oxygen/blood , Oxygenators , Placental Lactogen/biosynthesis , Pregnancy , Virus Diseases/transmission
14.
Early Pregnancy ; 1(4): 270-80, 1995 Dec.
Article in English | MEDLINE | ID: mdl-9363259

ABSTRACT

In long-term cultures of human chorionic villus explants, the viability of the tissue must be controlled to ensure the reliability of functional studies. Ionic levels (pH), gas concentrations (pO2, pCO2) and metabolic markers (glucose, lactate) in the culture medium are often utilized. Analyses of hormone, enzyme and protein levels are also frequently used to estimate viability. The purpose of this study was to evaluate whether in vitro release and immunoreactivity of human chorionic gonadotropin (hCG) and human placental lactogen (hPL) were correlated with the viability of first-trimester and full-term chorionic villus explants as determined by histopathology. Villus explants of first-trimester and full-term pregnancies were incubated in 6-well plates of RPMI medium which was supplemented with 10% fetal calf serum. Incubations were performed for 10 days, and the plates were kept at 37 degrees C under a water-saturated atmosphere containing 5% CO2 and 95% O2. The medium was replaced every day and samples of supernatant were frozen for later testing of hCG (first trimester) or hPL (full term), glucose consumption and lactate production. The tissue was also fixed and embedded for light-microscopic examination and immunocytochemistry. The hCG release remained stable during 6-7 days at a high level before decreasing, whereas hPL release decreased during the first 5-6 days then stabilized at a relatively low level. Only hCG kinetics were significantly different between tissue incubated with and without cycloheximide or iodoacetic acid. Both hCG and hPL immunoreactivity were not significantly different between tissue cultures with, and without, addition of cycloheximide or iodoacetic acid and even with morphological evidence of trophoblast and endothelial necrosis. The immunoreactivity for both hormones remains highly positive when the significant release has stopped, and does not reflect the tissue viability.


Subject(s)
Chorionic Villi/physiology , Placental Lactogen/metabolism , Chorionic Gonadotropin/analysis , Chorionic Gonadotropin/metabolism , Culture Media , Culture Techniques , Cycloheximide/pharmacology , Female , Glucose/metabolism , Humans , Immunohistochemistry , Iodoacetates/pharmacology , Iodoacetic Acid , Kinetics , Labor, Obstetric , Lactic Acid/metabolism , Placental Lactogen/analysis , Pregnancy , Pregnancy Trimester, First , Protein Synthesis Inhibitors/pharmacology
15.
Am J Pathol ; 147(1): 223-4, 1995 Jul.
Article in English | MEDLINE | ID: mdl-19970367
16.
Antimicrob Agents Chemother ; 38(1): 83-9, 1994 Jan.
Article in English | MEDLINE | ID: mdl-7511361

ABSTRACT

To assess the effects of antifungal therapy on the course of Candida albicans central nervous system infection and inflammation, we inoculated intracisternally 10(5) CFU of C. albicans into rabbits. Fluconazole (10 mg/kg of body weight) or amphotericin B (1 mg/kg) was infused intravenously daily for 14 days. Treatment was initiated 24 h or 5 days after infection. Cerebrospinal fluid (CSF) was repeatedly obtained to culture the organisms, assess the level of inflammation, and measure drug concentrations. Brain tissue was obtained at the end of therapy for culture, drug concentration determinations, and histopathology. The median number of days of treatment required to sterilize CSF cultures was 4 days for fluconazole therapy and 1 day for amphotericin B therapy (P = 0.037). There was a significant reduction in tumor necrosis factor alpha and leukocyte concentrations in the CSF of animals treated early versus those in untreated control animals (P < 0.05 and P < 0.001, respectively; analysis of variance). Compared with treated animals, a higher proportion of cultured CSF samples from untreated animals were positive for Candida (P < 0.001). A cultured brain sample from 1 of the 12 animals treated early with amphotericin B was positive for C. albicans (P < 0.01 versus controls); cultures of brain samples from 3 of 12 animals treated early with fluconazole were positive, whereas cultures of brain samples from 10 of 12 controls were positive (P < 0.05). The mean density of C. albicans was lower in the single culture-positive amphotericin B recipient (1 x 10(1) CFU/g of brain tissue) than in those treated with fluconazole (1 x 10(3) CFU/g) and in controls (8 x 10(4) CFU/g). In animals treated late, the density of C. albicans in the brain in relation to the number of days of therapy was significantly lower in amphotericin B recipients than in those treated with fluconazole (P < 0.01) and untreated controls (P < 0.01; analysis of covariance). By histopathology, a larger proportion of untreated animals compared with those treated early demonstrated features of severe infection such as perivasculitis, ventriculitis, and evidence of fungal organisms. Compared with amphotericin B-treated rabbits, those given fluconazole had a trend toward more severe pathologic lesions. Reduced susceptibility to both fluconazole and amphotericin B was observed in the C. albicans organisms isolated from the brain of one fluconazole-treated animal. These data suggest that amphotericin B is the preferred treatment for C. albicans infections of the central nervous system.


Subject(s)
Antifungal Agents/therapeutic use , Candidiasis/drug therapy , Meningitis, Fungal/drug therapy , Amphotericin B/therapeutic use , Animals , Antifungal Agents/pharmacokinetics , Antifungal Agents/pharmacology , Brain/microbiology , Candida albicans/drug effects , Candidiasis/microbiology , Candidiasis/pathology , Cytokines/cerebrospinal fluid , Fluconazole/therapeutic use , Inflammation/pathology , Interferons/blood , Leukocyte Count , Male , Meningitis, Fungal/microbiology , Meningitis, Fungal/pathology , Microbial Sensitivity Tests , Rabbits , Tumor Necrosis Factor-alpha/cerebrospinal fluid
17.
Am J Clin Pathol ; 100(1): 52-6, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8346737

ABSTRACT

The pathologic findings from biopsy or autopsy material in four patients, who were vaccinated with bacillus Calmette-Guérin (BCG) at birth in Chile, are presented. Two patients had severe combined immunodeficiency, and two had more restricted cellular (T-cell) immunodeficiency with no evidence of human immunodeficiency virus infection. The patients had distinct skin nodules and nodular lesions in systemic organs and bone marrow. Three patients had regional BCG lymphadenitis. One patient with severe combined immunodeficiency, however, had disseminated BCG without any local reaction. In all cases BCG strains of Mycobacterium were identified in a reference mycobacteriology laboratory. The histologic lesions in most patients usually consisted of diffuse histiocytic infiltrates with poorly formed granulomas and variable or no necrosis. Histiocytes were plump and engorged with numerous acid-fast bacilli (AFB). In some areas the massive histiocytosis resembled a spindle cell neoplasm. Other histologic findings supported the underlying immunodeficiency. The pattern of histiocytic response and degree of microbial killing depend on the host's immunocompetence. In the later stages of disease or in severe immunodeficiency, there is a lack of granuloma formation and unimpeded proliferation of AFB. These findings are reminiscent of nontuberculous mycobacterial infections in AIDS patients. Bacillus Calmette-Guèrin dissemination has to be considered in immunocompromised individuals when the patient comes from other countries in which such vaccinations are practiced.


Subject(s)
BCG Vaccine/adverse effects , Immunocompromised Host , Mycobacterium Infections/etiology , Mycobacterium bovis/immunology , BCG Vaccine/immunology , Child, Preschool , Humans , Infant , Infant, Newborn , Mycobacterium Infections/mortality , Mycobacterium Infections/pathology , Mycobacterium Infections/physiopathology , Mycobacterium bovis/isolation & purification
18.
Gastroenterology ; 104(6): 1669-77, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8500725

ABSTRACT

BACKGROUND: Plant lectins are present in significant quantity in a variety of food sources. The aim of this study was to determine if they stimulated growth of the intestine. METHODS: Germ-free and conventional rats were pair fed purified phytohemagglutinin lectin (PHA) or equivalent casein in a fully nutritious diet. PHA was instilled into in situ jejunal and ileal loops. Organ weight, length, DNA, protein content, morphometry, and [3H]thymidine uptake into jejunal crypt cells were measured. RESULTS: A trophic response occurred in the small intestine (jejunum greater than ileum) because of PHA (P < 0.001), was sustained by continued exposure, and was reversible on reinstitution of the control diet (P < 0.05). The intestinal microbial flora in conventional animals that were fed PHA augmented the growth-stimulatory effects of PHA on intestinal weight (P < 0.01). PHA caused fecal protein, fat, and mucous glycoprotein levels (P < 0.001) to increase in germ-free animals. PHA increased jejunal mucosal crypt depth and crypt mitotic activity (P < 0.05); DNA content (P < 0.05) and [3H]thymidine uptake (P < 0.01) into crypt cells was increased. No increase in plasma or tissue content of gastrin, enteroglucagon, or peptide YY was observed on PHA exposure, and there was no increase in organ weight of the liver, kidney, or colon. CONCLUSIONS: PHA stimulated growth of rat small intestine when present in the diet or instilled in the bowel lumen.


Subject(s)
Intestine, Small/growth & development , Phytohemagglutinins/pharmacology , Animals , DNA/biosynthesis , Germ-Free Life , Intestinal Mucosa/cytology , Intestinal Mucosa/growth & development , Intestine, Small/cytology , Male , Microvilli/ultrastructure , Mitotic Index , Organ Size , Rats , Rats, Sprague-Dawley
20.
Pediatr Pathol ; 12(3): 313-24, 1992.
Article in English | MEDLINE | ID: mdl-1409135

ABSTRACT

Previous studies have suggested that immune mechanisms contribute to lung injury in cystic fibrosis (CF); however, there have been no comprehensive studies of immunofluorescent staining patterns in CF lung tissue. We performed immunofluorescence (IF) studies for immunoglobulins, C3, and fibrinogen on autopsy frozen lung tissue from 21 CF patients. Results were compared with lung findings in patients without CF. In CF-derived lung tissue fibrinogen was ubiquitous along the alveolar wall, alveolar space, and interstitium. Free immunoglobulin G (IgG) and IgA coated the alveolar surface segmentally in 14 and 6 cases, respectively. Unequivocal interstitial deposits were infrequent and IgM was present in blood vessels in one patient only. Intra-alveolar and interstitial inflammatory cells demonstrated cytoplasmic IgG, IgA, and IgM, respectively, in 18, 14, and 6 patients. C3 was seen only segmentally along the alveolar wall in two patients and in blood vessels in one. Antinuclear antibody (ANA) staining of interstitial cells for C3 and immunoglobulins was seen in five patients, four of whom had interstitial pneumonitis. Insignificant amounts of alveolar or interstitial fibrinogen and immunoglobulins in inflammatory cells were seen in controls in the absence of lung inflammation. The IF patterns were similar in the inflammatory lesions of CF and control specimens. The IF patterns observed in CF lung tissue are consistent with nonspecific vascular leakage and chronic inflammation with little evidence of immune complex deposition in the interstitium or blood vessels. This study confirms previous reports of ANA activity in CF patients, although the significance of this finding is unknown.


Subject(s)
Cystic Fibrosis/immunology , Lung/immunology , Adolescent , Adult , Antigen-Antibody Complex/metabolism , Child , Complement C3/metabolism , Cystic Fibrosis/complications , Cystic Fibrosis/pathology , Female , Fibrinogen/immunology , Fibrinogen/metabolism , Fluorescent Antibody Technique , Humans , Immunoglobulins/metabolism , Lung/metabolism , Lung/pathology , Male , Pneumonia/complications , Pneumonia/immunology , Pneumonia/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...